Royal Bank Of Canada Amphastar Pharmaceuticals, Inc. Transaction History
Royal Bank Of Canada
- $458 Billion
- Q1 2025
A detailed history of Royal Bank Of Canada transactions in Amphastar Pharmaceuticals, Inc. stock. As of the latest transaction made, Royal Bank Of Canada holds 26,079 shares of AMPH stock, worth $658,755. This represents 0.0% of its overall portfolio holdings.
Number of Shares
26,079
Previous 28,632
8.92%
Holding current value
$658,755
Previous $1.06 Million
28.88%
% of portfolio
0.0%
Previous 0.0%
Shares
17 transactions
Others Institutions Holding AMPH
# of Institutions
258Shares Held
33.6MCall Options Held
20.8KPut Options Held
11.6K-
Black Rock Inc. New York, NY5.94MShares$150 Million0.01% of portfolio
-
Vanguard Group Inc Valley Forge, PA2.42MShares$61.2 Million0.0% of portfolio
-
Td Asset Management Inc2.21MShares$55.9 Million0.06% of portfolio
-
State Street Corp Boston, MA1.6MShares$40.5 Million0.0% of portfolio
-
Dimensional Fund Advisors LP Austin, TX1.36MShares$34.3 Million0.01% of portfolio
About Amphastar Pharmaceuticals, Inc.
- Ticker AMPH
- Exchange NASDAQ
- Sector Healthcare
- Industry Drug Manufacturers—Specialty & Generic
- Shares Outstandng 49,015,200
- Market Cap $1.24B
- Description
- Amphastar Pharmaceuticals, Inc., a bio-pharmaceutical company, develops, manufactures, markets, and sells generic and proprietary injectable, inhalation, and intranasal products in the United States, China, and France. The company operates through two segments, Finished Pharmaceutical Products and API. It offers Primatene Mist, an over-the-count...